We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$24B
AUM Growth
+$2.89B
Cap. Flow
+$2.75B
Cap. Flow %
11.43%
Top 10 Hldgs %
10.27%
Holding
2,691
New
770
Increased
420
Reduced
344
Closed
817

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Financials 12.28%
3 Industrials 10.64%
4 Consumer Discretionary 9.58%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSXMA
401
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$15.5M 0.06%
447,516
-393,406
-47% -$13.7M
IFF icon
402
International Flavors & Fragrances
IFF
$21.7B
$15.5M 0.06%
+115,668
New +$17M
LITE icon
403
CALL
Lumentum
LITE
$63.3B
$15.5M 0.06%
+185,000
New +$15.5M
PM icon
404
Philip Morris
PM
$290B
$15.4M 0.06%
162,873
-70,295
-30% -$7.07M
HELE icon
405
Helen of Troy
HELE
$680M
$15.4M 0.06%
68,713
+45,033
+190% +$10.3M
MTCH icon
406
PUT
Match Group
MTCH
$8.43B
$15.4M 0.06%
+98,100
New +$14.9M
COLM icon
407
Columbia Sportswear
COLM
$2.92B
$15.3M 0.06%
159,546
+150,249
+1,616% +$15.2M
NBIX icon
408
Neurocrine Biosciences
NBIX
$16.8B
$15.3M 0.06%
+159,324
New +$15M
ONEM
409
DELISTED
1Life Healthcare
ONEM
$15.3M 0.06%
+753,236
New +$19.4M
CGNX icon
410
Cognex
CGNX
$10.8B
$15.2M 0.06%
189,694
-211,545
-53% -$18.2M
GMED icon
411
Globus Medical
GMED
$11.7B
$15.2M 0.06%
198,504
+31,751
+19% +$2.55M
EEM icon
412
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$15.1M 0.06%
300,000
+289,184
+2,674% +$15.1M
VYX icon
413
NCR Voyix
VYX
$1.09B
$15M 0.06%
631,524
+380,600
+152% +$9.9M
THC icon
414
Tenet Healthcare
THC
$20.9B
$15M 0.06%
225,651
+165,028
+272% +$11.7M
MTAL
415
DELISTED
Metals Acquisition
MTAL
$15M 0.06%
+1,498,817
New +$14.7M
MA icon
416
Mastercard
MA
$493B
$15M 0.06%
43,045
-241,108
-85% -$87.7M
IOVA icon
417
CALL
Iovance Biotherapeutics
IOVA
$2.9B
$14.9M 0.06%
605,000
+540,000
+831% +$12.7M
TMHC
418
DELISTED
Taylor Morrison
TMHC
$14.9M 0.06%
578,571
+153,063
+36% +$4.05M
RIDE
419
CALL
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$14.8M 0.06%
+124,000
New +$12.9M
EQC
420
DELISTED
Equity Commonwealth
EQC
$14.8M 0.06%
567,927
+420,453
+285% +$11.1M
CDNS icon
421
Cadence Design Systems
CDNS
$91.4B
$14.7M 0.06%
+96,964
New +$14.8M
CHNG
422
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$14.6M 0.06%
698,054
+549,050
+368% +$12M
MAA icon
423
Mid-America Apartment Communities
MAA
$15.4B
$14.5M 0.06%
77,470
+40,969
+112% +$7.69M
CNMD icon
424
CONMED
CNMD
$1.48B
$14.5M 0.06%
+110,571
New +$14.5M
TLT icon
425
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
$14.4M 0.06%
+100,000
New +$14.8M

Similar funds

Balyasny Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Balyasny Asset Management held 2,691 positions worth $24B, up 14% from $21.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Balyasny Asset Management deployed $2.75B of net new capital in Q3 2021, opening 770 new positions and adding to 420 existing holdings. Its largest new stake was Salesforce: 556,949 shares worth $151M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Fortive, an estimated $138M trimmed.

  • Balyasny Asset Management's largest Q3 2021 buy was Salesforce: 556,949 shares worth $151M.
  • Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $537M increase.
  • Balyasny Asset Management's biggest Q3 2021 reduction was Fortive, cutting an estimated $138M.
  • Balyasny Asset Management fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $172M.
  • Balyasny Asset Management's ten largest holdings make up 10% of its $24B portfolio in Q3 2021.
  • Balyasny Asset Management opened 770 new positions and closed 817 in Q3 2021.
  • Balyasny Asset Management's portfolio value rose 14% quarter-over-quarter to $24B.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.